AstraZeneca's Forxiga approved in China to reduce cardiovascular death
GSK's respiratory syncytial virus vaccine receives approval
AstraZeneca's anti-diabetes drug approved in China
Revvity announces license agreement for base editing tech with AstraZeneca
Farxiga extended in the US to reduce risk of cardiovascular death
AstraZeneca's drug approved in EU for treatment of symptomatic heart failure
Tickets now on sale for 2023 Manufacturing Chemist Live
AstraZeneca antibody combination approved for COVID prevention
Therapeutic: abrocitinib for atopic dermatitis
Therapeutic: daprodustat for anaemia
Therapeutic: tezepelumab for asthma
4D pharma, Merck and Pfizer trial combination carcinoma treatment
Pharma CEOs pledge to uphold scientific standards for COVID vaccine
Therapeutics: nirsevimab for RSV prophylaxis
Therapeutics: anticancer agent
ABPI: Tackling vaccine hesitancy should be a priority